Evidence map›Paper›PMID 41780890›Full record

ArticleMolecular & cellular proteomics : MCP2026

Generalizable Direct Protein Sequencing With InstaNexus.

Marco Reverenna, Maike Wennekers Nielsen, Darian Stephan Wolff, Jemma Daniel, Elpida Lytra, Suthimon Thumtecho, Pasquale D Colaianni, Anne Ljungars, Andreas H Laustsen, Erwin M Schoof and 5 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marco ReverennaNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Maike Wennekers NielsenDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Darian Stephan WolffDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark; Novonesis, Lyngby, Denmark.
Jemma DanielInstaDeep Ltd, London, UK.
Elpida LytraDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark; Center for Translational Protein Design, Technical University of Denmark, Lyngby, Denmark.
Suthimon ThumtechoDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Pasquale D ColaianniNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Anne LjungarsDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Andreas H LaustsenDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Erwin M SchoofDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Jeroen Van GoeyDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Timothy P JenkinsDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark; Center for Translational Protein Design, Technical University of Denmark, Lyngby, Denmark.
Marie V LukassenDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Alberto SantosNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark. Electronic address: albsad@biosustain.dtu.dk.
Konstantinos KalogeropoulosDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark; Center for Translational Protein Design, Technical University of Denmark, Lyngby, Denmark; Department of Bionanoscience, Delft University of Technology, Delft, Netherlands; Kavli Institute of Nanoscience, Delft, Netherlands. Electronic address: konka@dtu.dk.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Accurate determination of protein sequences is central to biology. Protein-based therapeutics, such as antibodies and nanobodies, are not encoded in reference genomes, challenging their accurate characterization via standard proteomics. Current methods rely on indirect inference, fragmented outputs, and labor-intensive workflows, which hinder functional insights and routine application. Here, we present a generalizable, end-to-end workflow for direct protein sequencing, combining streamlined sample preparation, artificial intelligence (AI)-driven de novo peptide sequencing, and tailored assembly to reconstruct contiguous protein sequences. A novel composite scoring framework prioritizes longer assemblies and coverage, enhancing accuracy and reducing ambiguity. Validation across diverse protein modalities demonstrates its utility and ability to robustly sequence functionally critical regions of selected proteins. This workflow represents an advance in precision proteomics with promising applications in therapeutic discovery, immune profiling, and protein science.

Indexed as

ProteinsProteomicsSequence Analysis, ProteinAmino Acid SequenceHumansProteinsde novo sequencingprotein assemblyprotein sequencingsample preparationtherapeutics

Identifiers

PMID41780890
PMCPMC13084398

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.